Author: Greg Richter

Greg covers Medicine, Public Health, Biomedical Engineering, Science and Health Systems. He graduated from Rowan University, where he also worked in its Office of Media and Public Relations and also had a brief stint as its mascot for the opening of its medical school. Before Drexel, he worked in Penn Medicine’s Office of Communications, most recently as a senior medical communications officer. When not covering news at Drexel, he’s trying out a new recipe or trying to decide if he actually enjoys running. Follow him @DrexelGreg or view his blog posts here. Contact Greg at gdr33@drexel.edu or 215-895-2614.
Read More

Q&A: Should Allergy Sufferers Experiencing Facial Redness Re-Think Using Popular Nasal Sprays?

Corticosteroids creams or lotions are commonly prescribed to reduce inflammation that causes facial redness. They’re also the main ingredient in popular nasal sprays that aim to combat inflammatory responses that cause sinus issues. Now a recently published report in the journal Archives of Dermatological Research suggests that these widely prescribed medications may have a link with rosacea-like skin redness.

Read More
thermometers

Q+A: How are Increasing Days of Extreme Temperatures Impacting the Health of Those In Pennsylvania’s Prisons?

As both the number of days with extreme temperatures fueled by climate change and the number of incarcerated Americans increases (roughly two million people are currently incarcerated in the U.S.), a new health crisis is emerging for many of those in Pennsylvania’s prisons, particularly for women, according to a recently published study in Nature Communications from researchers at the Dornsife School of Public Health.

Read More

Q+A: A New COVID Variant is Spreading Across the United States. Should We Be Concerned?

A new COVID “variant under monitoring” by the World Health Organization known as BA.3.2 is circulating across the United States. Here to sort out the latest on the new variant, including whether we should be concerned about its ability to evade immunity from previous vaccination and/or previous SARS-CoV-2 infection, is Sonia Navas-Martin, PhD, a professor of microbiology and immunology in Drexel’s College of Medicine.